SRPT

Sarepta Therapeutics, Inc. News Headlines

$38.82
*  
0.03
 negative 
0.08%
Get SRPT Alerts
*Delayed - data as of Apr. 23, 2014 11:20 ET 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    SRPT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
4/22/2014 4:45:01 PM - Zacks.com

MARKET SNAPSHOT: Stocks Rise; S&P 500 In Longest Win Streak In 6 Mths
4/21/2014 4:49:00 PM - Dow Jones Business News

SRPT Crosses Above Key Moving Average Level
4/21/2014 11:41:53 AM - BNK Invest

Sarepta Therapeutics Inc. (SRPT) Has Jumped To A 5-Month High On Eteplirsen News
4/21/2014 9:33:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
4/21/2014 9:14:00 AM - Dow Jones Business News

U.S. Stock Futures Mixed Before Open as Investors Sift Through Earnings
4/21/2014 9:13:33 AM - MT Newswires

U.S. Stock Futures Edge Higher; Companies Report Mixed Earnings
4/21/2014 8:50:43 AM - MT Newswires

Pre-Market Most Active for Apr 21, 2014 : NMR, SRPT, AMD, NEM, ABX, FB, AZN, MU, JASO, BAC, WB, CBEY
4/21/2014 8:39:52 AM - NASDAQ.com News

Sector Update: Health Care
4/21/2014 8:22:04 AM - MT Newswires

Sector Update: Health-Care Shares Flat Pre-Market; Sarepta Soars 75% on New Drug Application Plans for Eteplirsen
4/21/2014 8:18:57 AM - MT Newswires

Sarepta Therapeutics To Submit NDA For Eteplirsen By Year End 2014 - Quick Facts
4/21/2014 7:04:00 AM - RTT News

Sarepta Therapeutics To Present At Needham Conference ; Webcast At 12:10 PM ET
4/8/2014 11:10:00 AM - RTT News

Why Now Is The Time To Get Behind Sarepta Therapeutics
4/1/2014 2:41:00 AM - Seeking Alpha

Looking For Value Among Biotechs After Precipitous Declines In Stock Price
3/24/2014 12:26:00 PM - Seeking Alpha

Prosensa Rises on Encouraging Data - Analyst Blog
3/19/2014 5:20:01 PM - Zacks.com

Prosensa Shares Jump on 'Encouraging' Phase II Drug Study
3/17/2014 7:28:00 PM - Dow Jones Business News

On Sarepta's 2013 Results And Upcoming Events
3/4/2014 9:57:00 AM - Seeking Alpha

Sarepta Therap. To Present At Cowen & Co. Conference; Webcast At 9:20 AM ET
3/4/2014 8:20:00 AM - RTT News

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints
2/27/2014 9:26:00 AM - MT Newswires

Sector Update: Healthcare
2/27/2014 9:22:40 AM - MT Newswires

Earnings Reaction History: Sarepta Therapeutics, Inc., 50.0% Follow-Through Indicator, 8.6% Sensitive
2/27/2014 7:25:25 AM - MT Newswires

Sarepta (SRPT) Enters Overbought Territory - Tale of the Tape
2/26/2014 7:52:01 AM - Zacks.com

SRPT: Insiders vs. Shorts
2/25/2014 3:26:53 PM - BNK Invest

Chen Lin's Perfect Biotech Market Prescription: Buy Low, Sell High
2/21/2014 10:00:00 AM - Seeking Alpha

Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha